TCTMD

Lactate Clearance May Act as ‘Early Warning Sign’ in Cardiogenic Shock

The new SCAI initiative brings optimism for a population that has seen little innovation or changes to treatment paradigms in ...
Medscape

No TRIUMPH for tilarginine in cardiogenic shock

New Orleans, LA - The nitric-oxide-synthase inhibitor tilarginine (ArgiNOx Pharmaceuticals) had no effect on mortality in patients with refractory cardiogenic shock complicating MI in the TRIUMPH ...
Healio

Routine use of Impella CP for STEMI-related cardiogenic shock confers survival benefit

Please provide your email address to receive an email when new articles are posted on . Risk for death was lower with the pump vs. standard care only, but incidence of adverse events was elevated. The ...

New initiative targets faster shock diagnosis and care with 'door to lactate clearance'

A new initiative by The Society for Cardiovascular Angiography & Interventions (SCAI) proposes a new framework and call to ...
News Medical

Study: One in four early cardiogenic shock patients experience worse outcomes

In one of the largest studies of early cardiogenic shock (CS) patients, where blood flow is still functioning to vital organs, researchers demonstrated that 26% experienced worse outcomes, including ...
Medscape

Impella CP Improves Survival in STEMI, Cardiogenic Shock

Use of a microaxial flow pump (Impella CP) with standard care led to a lower risk for death than standard care alone in patients with ST-elevation myocardial infarction (STEMI)-related cardiogenic ...
TCTMD

How Cardiogenic Shock Working Group (CSWG) Registry Findings have Advanced Understanding of Pathophysiology, Prognosis and Therapeutics

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
Hosted on MSN

Researchers find cognitive impairment is common after cardiogenic shock

Many survivors of cardiogenic shock showed evidence of new cognitive impairment after leaving the hospital, according to a study led by UT Southwestern Medical Center researchers. The findings, ...
Hosted on MSN

Windtree Showcases Promising Istaroxime Data for Cardiogenic Shock at Major Conference

WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has unveiled new data on istaroxime, a treatment candidate for cardiogenic shock, at the European Society of Cardiology Heart Failure 2025 ...
Nasdaq

Windtree Therapeutics Advances Istaroxime Cardiogenic Shock Program with SEISMiC C Study Interim Analysis Planned for July 2025

Windtree Therapeutics, Inc. announced that it is preparing for an interim analysis of its SEISMiC C Phase 2 study of istaroxime, targeting results for July 2025. This global, placebo-controlled, ...
MedPage Today

Impella Pump Improves Survival in STEMI-Related Cardiogenic Shock

ATLANTA -- Routine use of the Impella CP microaxial flow pump significantly improved survival in patients with infarct-related cardiogenic shock, the randomized DanGer Shock trial showed. In more than ...